Partner Headlines - CLSN

  1. Morning Market Gainers

    Benzinga
  2. UPDATE: Celsion Slightly Falls Back Following Treatment News

    Benzinga
  3. Celsion Jumps On Interim Data On Cancer Drug

    Benzinga
  4. Morning Market Gainers

    Benzinga
  5. Benzinga's Top Initiations

    Benzinga
  6. Celsion Presents Preclinical Data For Its TheraSilence Platform ...

    Benzinga
  7. Morning Market Movers

    Benzinga
  8. Benzinga's M&A Chatter for Tuesday June 10, 2014

    Benzinga
  9. Celsion to Present Updated Overall Survival Results from HEAT ...

    Benzinga
  10. Celsion Says Recent Analysis Indicates ThermoDox Could Significantly ...

    Benzinga
  11. Mornings Movers for Feb. 28, 2014: CETV, OTVI, MELI, REGI, GALE ...

    Benzinga
  12. Celsion Announces $15M At-The-Market Registered Direct Offering ...

    Benzinga
  13. Morning Market Movers

    Benzinga
  14. Celsion Presents Combined Clinical Data from Two Phase I Trials ...

    Benzinga
  15. Celsion Announces Zhejiang HISUN Pharmaceutical does Not Plan ...

    Benzinga
  16. Stocks Hitting 52-Week Lows

    Benzinga
  17. Celsion Halted Wednesday, Says Will Host Conference Call Jan ...

    Benzinga
  18. Option Speculators Circle Celsion

    SchaeffersResearch
  19. Stocks Hitting 52-Week Highs

    Benzinga
  20. UPDATE: Dawson James Initiates Celsion at Market Outperform on ...

    Benzinga
  21. Celsion Corp Says Continuing Phase 2 Study

    Benzinga
  22. Celsion Corporation (CLSN) CEO Michael H Tardugno buys 5,000 ...

    GuruFocus
  23. Celsion Thermodox Gets Orphan Drug Status in US/Europe

    Benzinga
  24. Health Care Sector Wrap

    FoxBusiness
  25. Gap, General Motors Among Stocks Up on High Volume Friday

    FoxBusiness
  26. Call Volume Surges as Celsion Extends Its Rally

    SchaeffersResearch
  27. Celsion Announces Collaboration With the University of Oxford ...

    Benzinga
  28. Celsion Announces Resubmission With Philips Healthcare of Combined ...

    Benzinga
  29. Celsion Announces ThermoDox Commercial Supply Agreement With ...

    Benzinga
  30. Rodman & Renshaw Maintains Outperform on Celsion

    Benzinga
  31. Celsion Completes Consultative Review Process With EMA for Phase ...

    Benzinga
  32. Celsion Corp. (CLSN) CEO Michael H Tardugno buys 5,000 Shares

    GuruFocus
  33. Celsion Corp. (CLSN) CFO Gregory L Weaver buys 5,000 Shares

    GuruFocus
Trading Center